Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function

Carta Revisado por pares

Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function

2013; Elsevier BV; Volume: 169; Issue: 5 Linguagem: Inglês

10.1016/j.ijcard.2013.10.040

ISSN

1874-1754

Autores

Nileshkumar Patel, Michael Hoosien, Abhishek Deshmukh, Apurva O. Badheka, Peeyush Grover, Neeraj Shah, Vikas Singh, Kathan Mehta, Ankit Chothani, Ghanshyambhai T. Savani, Shilpkumar Arora, Vipulkumar Bhalara, Nilay Patel, Dhaval Khalpada, Ankit Rathod, Thomas J. Vazzana, James Lafferty, Juan F. Viles-González, Raul D. Mitrani,

Tópico(s)

Cardiac Arrhythmias and Treatments

Resumo

Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function☆☆☆ Nileshkumar J. Patel , Michael Hoosien , Abhishek Deshmukh , Apurva O. Badheka , PeeyushM. Grover , Neeraj Shah , Vikas Singh , KathanMehta , Ankit Chothani , Ghanshyambhai T. Savani , Shilpkumar Arora , Vipulkumar Bhalara , Nilay Patel , Dhaval Khalpada , Ankit Rathod , Thomas J. Vazzana , James Lafferty , Juan F. Viles-Gonzalez , Raul D. Mitrani b,⁎

Ver no editor

Altmetric

PlumX

Entrar

Lembrar minha senha

Receber meu e-mail de confirmação

Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function